Overview of Presentation. Background. Discipline Review Letter (DRL). Information Request (IR). IR/DRL Timing . IR/DRL Responses. Key Takeaways. Resources. www.fda.gov. Background. The Generic Drug User Fee Amendments of 2017 (GDUFA II) was signed into law on August 18, 2017 in order to facilitate .... ID: 751448
DownloadNote - The PPT/PDF document "Draft Guidance for Industry: Information..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.